Search for: "Generic Pharmaceutical Services, Inc." Results 301 - 320 of 1,028
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Dec 2016, 12:05 am by Jeffrey May
The Antitrust Division announced charges against Jeffrey Glazer, the former chief executive officer of generic pharmaceutical company Heritage Pharmaceuticals, Inc., and Jason Malek, the former president of the same company. [read post]
12 Dec 2016, 1:00 am by Matrix Legal Support Service
Habib Khan v General Pharmaceutical Council, heard 10 November 2016. [read post]
5 Dec 2016, 12:30 am by Matrix Legal Support Service
Habib Khan v General Pharmaceutical Council, heard 10 November 2016. [read post]
27 Nov 2016, 11:00 pm by Matrix Legal Support Service
Habib Khan v General Pharmaceutical Council, heard 10 November 2016. [read post]
21 Nov 2016, 1:15 am by Matrix Legal Support Service
Habib Khan v General Pharmaceutical Council, heard 10 November 2016. [read post]
15 Nov 2016, 9:07 am by Schachtman
See Surgeon General’s Advisory Committee on Smoking and Health, Smoking and Health (Office of the Surgeon General, United States Public Health Service 1964). [read post]
14 Nov 2016, 1:00 am by Matrix Legal Support Service
Habib Khan v General Pharmaceutical Council, heard 10 November 2016. [read post]
7 Nov 2016, 1:15 am by Matrix Legal Support Service
On Thursday 10 November, the Supreme Court will hear the appeal of HK v General Pharmaceutical Council. [read post]
2 Sep 2016, 1:57 pm by John Stigi
  There, plaintiffs brought a putative class action complaint challenging the sale of Auspex Pharmaceuticals, Inc. to Teva Pharmaceuticals Industries, Inc. [read post]
29 Aug 2016, 1:19 pm by Michael Grossman
While Janssen Pharmaceutical and Johnson & Johnson can be held liable for the damages caused by Risperdal and Invega, a 2011 decision by the United States Supreme Court protects most makers of generic risperidone/paloperidone from litigation. [read post]
14 Jul 2016, 2:37 pm by Eric Caligiuri
Hospira Inc., Federal Circuit case number 2014-1469, that to be “on sale” under pre-AIA 35 U.S.C. [read post]
6 May 2016, 12:30 pm
Tap Pharmaceuticals, Inc., 2004 WL 2550593, at *5 (W.D. [read post]
3 May 2016, 9:00 pm by Dennis Crouch
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1]  On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]